Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlling Blood Pressure in Treatment Resistant Hypertension
NCT02167464Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jun 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of spironolactone in hypertension (HTN) (4 arms), sponsored by Medical University of South Carolina. Primary endpoint: Blood Pressure Control at 4 months. Started Jun 2011; status: completed.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02167464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167464.